Total item
Cart Subtotal
$0.00 Cannabinoid Receptors
24 Item(s)
per page
-
Taranabant ((1R,2R)stereoisomer)
Catalog No. A21705 CB1 receptor inverse agonistTaranabant (1R,2R)stereoisomer is the R-enantiomer of Taranabant. Taranabant is a highly potent and selective cannabinoid 1 (CB1) receptor inverse agonist. Learn More -
Taranabant racemate
Catalog No. A21699 CB1 antagonist/inverse agonistTaranabant racemate is an antagonist and/or inverse agonist of the Cannabinoid-1 (CB1) receptor extracted from patent WO 2004048317 A1. Learn More -
(±)-Ibipinabant
Catalog No. A21439 CB-1 receptor antagonist(±)-Ibipinabant ((±)-SLV319) is the racemate of SLV319. (±)-Ibipinabant ((±)-SLV319) is a potent and selective cannabinoid-1 (CB-1) receptor antagonist with an IC50 of 22 nM. Learn More -
JD-5037
Catalog No. A20837 CB1R antagonistJD-5037 is a novel, peripherally restricted CB1R antagonist with an IC50 of 1.5 nM. Learn More -
Taranabant
Catalog No. A11578 CB1 receptor inverse agonistTaranabant is a highly potent and selective cannabinoid 1 (CB1) receptor inverse agonist that inhibits the binding and functional activity of various agonists, with a binding Ki of 0.13 nM for the human CB1R in vitro. Learn More -
SR 144528
Catalog No. A12376 CB2 inverse agonistSR 144528 is a selective peripheral cannabinoid receptor inverse agonist that displays a Ki value of 0.6 nM for rat spleen and human recombinant CB2 receptors and a Ki value of 400 nM for rat brain and human recombinant CB1 receptors. Learn More -
CB2R-IN-1
Catalog No. A12306 cannabinoid CB2 receptor inverse agonistCB2R-IN-1 is a potent cannabinoid CB2 receptor inverse agonist with a Ki of 0.9 nM. Learn More -
CB1 antagonist 2
Catalog No. A18810 CB1 antagonistCB1 antagonist 2 is caimabinoid 1 (CB1) antagonist extracted from patent WO2016184310A1, compound 3, inhibits CB1 in vivo with an IC50 of 25.5 nM. Learn More -
GNE-049
Catalog No. A20206 CBP inhibitorGNE-049 is a highly potent and selective CBP inhibitor with an IC50 of 1.1 nM in TR-FRET assay. GNE-049 also inhibits BRET and BRD4(1) with IC50s of 12 nM and 4200 nM, respectively. Learn More -
VCE-004.8
Catalog No. A18549 PPARγ and CB2 receptor dual agonistVCE-004.8, a semi-synthetic multitarget cannabinoquinoid, is a specific PPARγ and CB2 receptor dual agonist with potent anti-inflammatory activity. Learn More -
Bay 59-3074
Catalog No. A16328 CB1/CB2 receptor agonistBay 59-3074 is a novel, selective CB1/CB2 receptor partial agonist with Ki values of 48.3 and 45.5 nM at human CB1 and CB2 receptors respectively . Learn More -
Rimonabant hydrochloride
Catalog No. A11548 CB1 receptor inverse agonistRimonabant hydrochloride is a CB1 receptor inverse agonist. Learn More -
AM1241
Catalog No. A16397 CB2 receptor agonistAM1241 is a selective cannabinoid CB2 receptor agonist with Ki of 3.4 nM, exhibits 82-fold selectivity over CB1 receptor. Learn More -
WIN 55,212-2 mesylate
Catalog No. A11932 CB receptor agonistWIN 55,212-2 is a potent cannabinoid receptor agonist that has been found to be a potent analgesic in a rat model of neuropathic pain. It activates p42 and p44 MAP kinase via receptor-mediated signaling. Learn More -
AM630
Catalog No. A14993 CB2 antagonistAM630 is a selectivity CB2 antagonist with Ki of 31.2 nM, > 150 fold selectivity over CB1 receptor. Learn More -
Otenabant
Catalog No. A15200 CB1 receptor antagonistOtenabant is a recently discovered selective, high affinity, competitive CB1 receptor antagonist with Ki of 0.7 nM. Learn More -
Tedalinab
Catalog No. A14189 CB2 receptor agonistTedalinab (GRC-10693) is a drug developed for the treatment of osteoarthritis and neuropathic pain, which acts as a potent and selective cannabinoid CB2 receptor agonist. It has a very high selectivity of 4700x for CB2 over the related CB1 receptor, has good oral bioavailability and has shown promising safety results and effective analgesic and antiinflammatory actions in early clinical trials. Learn More -
AM251
Catalog No. A12914 CB1 receptor antagonistAM251 is a potent CB1 receptor antagonist (IC50 = 8 nM, Ki = 7.49 nM) that displays 306-fold selectivity over CB2 receptors. Learn More -
Org 27569
Catalog No. A11513 CB1 modulatorOrg 27569 is a potent CB1 receptor allosteric modulator (pEC50 = 8.24). Learn More -
Rimonabant (SR141716)
Catalog No. A11547 Rimonabant is a selective antagonist of CB1 with IC50 of 13.6 nM and EC50 of 17.3 nM in hCB1 transfected HEK 293 membrane. Learn More -
GW842166X
Catalog No. A11253 CB2 receptor agonistGW842166X is a selective non-cannabinoid CB2 receptor agonist, which is undergoing clinical development as a novel oral treatment for inflammatory pain Learn More -
CP 945598 HCl (Otenabant HCl)
Catalog No. A11942 -
MDA 19
Catalog No. A11939 CB2 agonistMDA 19 is a potent and selective agonist for the cannabinoid receptor CB2, with reasonable selectivity over the psychoactive CB1 receptor. Learn More -
BML-190
Catalog No. A11938 CB2 receptor ligandBML-190 is a selective inverse agonist of the human cannabinoid CB2 receptor. Learn More
24 Item(s)
per page
FILTER BY:
Shopping Options
- Actions
-
- Inhibitor (1)
- Agonist (12)
- Antagonist (8)
- Modulator (1)
Adooq Quality Guarantee
We promise all products perform as described.